MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0929867327666191213104841

Медицинская библиотека · Current medicinal chemistry · 2020

Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?

Zacharia Effimia, Zacharias Konstantinos, Papamikroulis George-Angelo, Bertsias Dimitrios, Miliou Antigoni, Pallantza Zoi, Papageorgiou Nikolaos, Tousoulis Dimitris

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite the recent advances in the treatment of Acute Coronary Syndromes (ACS), patients with ACS are still exposed to an increased risk for adverse cardiovascular events, while their prognosis is difficult to determine. Experimental and clinical studies have shown that cell-derived Microparticles (MPs) are associated with the underlying pathophysiological processes that are responsible for atherogenesis and may be causally implicated in the induction of atherothrombosis.

OBJECTIVE

In the present article, we aimed to review the available evidence regarding the predictive role of MPs in patients with ACS.

RESULTS

Evidence suggests that endothelial MPs are associated with future adverse cardiovascular events in patients with ACS. Platelet-derived MPs have been excessively studied, since they have been found to trigger the coagulation cascade; however, their role as predictors of future cardiovascular events remains debatable. The role of red blood cell-derived MPs is more intriguing; they have been proposed as markers of ongoing thrombosis in patients with ACS, while previous studies have shown that they have anti-coagulant properties in healthy individuals. Leukocyte-derived MPs may also have a predictive role, although the studies regarding these are still limited. Last but not least, it was an interesting discovery that circulating MPs can provide information regarding the angiographic lesions in patients with ACS.

CONCLUSION

The concept of MPs as potential circulating biomarkers in patients with ACS holds much promise. However, large-scale clinical studies are required to evaluate whether the measurement of plasma MPs could be of clinical significance and, thus, dictate a more aggressive treatment strategy in patients with high levels of circulating MPs.

Для цитирования: Zacharia Effimia, Zacharias Konstantinos, Papamikroulis George-Angelo, Bertsias Dimitrios, Miliou Antigoni, Pallantza Zoi, Papageorgiou Nikolaos, Tousoulis Dimitris. Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?. Current medicinal chemistry. 2020. DOI: 10.2174/0929867327666191213104841.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.